Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.
about
Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study.Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants.Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgeryRemodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk.Dexamethasone Suppressed LPS-Induced Matrix Metalloproteinase and Its Effect on Endothelial Glycocalyx Shedding.TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model.Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.Smoothelin-B is not a target of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats.Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.Vascular receptors as new substrates for matrix metalloproteinases in hypertension and other inflammatory states.The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species.Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.
P2860
Q33560555-021205D3-20BF-47A3-BE0C-81FE08E57705Q34274138-F9F6CBB6-EC22-43BC-99D6-9CA98734A7F9Q34999581-1C57E32E-D80B-4B70-B378-CD844BE9B798Q35151494-243825C6-75BB-4CC9-90F1-52C6728F78C5Q35823888-4E75B048-3071-4D4B-9CC3-7CEB975C4B9DQ37639014-FEEF18D9-D689-41E4-B073-97A6E3DFEB2FQ37978478-BFB91FF6-A1D2-44C2-83CD-09411400451DQ39042927-B10E2E07-929D-4D38-9DED-63112B97E2A5Q41720328-29E5D061-A0B5-4119-A929-90824523637CQ42149468-6E67BD80-A088-4066-B8A1-2BB5B5A46200Q42733133-BEA45D15-8C90-46F9-9807-98D618FC5DC0Q42844378-39AFB0FB-9C5C-4523-B06D-8BE4CC0C0A14Q48131318-BDE0C886-68E4-4BDC-9A01-16095836FFE2Q49188523-BAF246E6-0583-4797-839F-9238932BE2E0
P2860
Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@ast
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@en
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@nl
type
label
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@ast
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@en
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@nl
prefLabel
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@ast
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@en
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@nl
P2093
P2860
P1476
Inhibition of matrix metallopr ...... hyporeactivity in endotoxemia.
@en
P2093
Ava K Chow
Edwin E Daniel
Jonathan J Cena
Manoj M Lalu
Mariel L Bagdan
Michele M Castro
Woo Jung Cho
P2860
P304
P356
10.1152/AJPHEART.00273.2009
P577
2009-10-16T00:00:00Z